Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trialBruce S. Stambler, Denise Sorrentino, Marco Alings et al.|The Lancet|2023Cited by 38